Skip to main content
. 2024 Jul 26;12(8):1529. doi: 10.3390/microorganisms12081529

Table 2.

Phenotypic antimicrobial resistance in the Salmonella spp. from the 15 markets sampled.

State Market Antimicrobial
Resistance
Types
Number of Isolates Antimicrobial Resistance Type No. (%)
Benue Otukpo CN, C, LEV, AZM, SXT, AMP, TE 6 7/13 (53.8)
Modern Market CTX, CN, AMP, TE 4 4/13 (30.8)
Wurukum None 0 0/13 (0)
Gboko C, SXT, TE 2 3/13 (23.1)
Yandev SXT 1 1/13 (7.7)
Kwara Sango AZM, AMP 2 2/13 (15.4)
Oja-Oba CTX, AMP 2 2/13 (15.4)
Ipata AMP 1 1/13 (7.7)
Share None 0 0/13 (0)
Oke-Oyi C, AZM, SXT, AMP, TE 4 5/13 (38.5)
Plateau Mangu AMP 1 1/13 (7.7)
Bokkos C, SXT, TE 2 3/13 (23.1)
Shendam TE 1 1/13 (7.7)
Yankaji CTX, SXT, AMP, TE, CAZ 3 5/13 (38.5)
Kugiya F, AZM, AMP, TE 2 4/13 (30.8)

Legend: AMP: Ampicillin, AZM: Azithromycin, CTX: Cefotaxime, TE: Tetracycline, CN: Gentamicin SXT: Sulphamethoxazole-Trimethoprim, C: Chloramphenicol, CAZ: Ceftazidime, LEV: Levofloxacin, F: Nitrofurantoin.